A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 27387881.
- Also identified by DOI 10.1038/nm.4131 and PMC identifier 7096003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As part of the World Health Organization (WHO) R&D Blueprint initiative, leading stakeholders on Middle East respiratory syndrome coronavirus (MERS-CoV) convened to agree on strategic public-health goals and global priority research activities that are needed to combat MERS-CoV. The online version of this article (doi:10.1038/nm.4131) contains supplementary material, which is available to authorized users.
Medical subject headings
- Antiviral Agents
- Coronavirus Infections
- Middle East Respiratory Syndrome Coronavirus
- Research
- Viral Vaccines